Richard A. Gonzalez

Richard A. Gonzalez is the Chairman of the Board and Chief Executive Officer of AbbVie, a prominent global biopharmaceutical company with a workforce of approximately 50,000 employees and a presence in over 175 countries. With a distinguished career spanning over three decades at Abbott Laboratories, Gonzalez played a pivotal role in the establishment of AbbVie as a separate entity from Abbott in 2013.

Prior to the separation, Gonzalez served as President and Chief Operating Officer of Abbott, and he briefly retired in 2007. Throughout his tenure at Abbott, he held various senior leadership positions within the company's medical products businesses, including President and Chief Operating Officer of the Medical Products Group, Senior Vice President and President of the former Hospital Products Division, Vice President and President of the Health Systems Division, and Divisional Vice President and General Manager for Diagnostics Operations in the United States and Canada.

Beyond his professional achievements, Gonzalez has been actively involved in the Chicago community. He is a member of the Commercial Club of Chicago and represents AbbVie on their Civic Committee. Additionally, he is a member of the Business Roundtable, an organization exclusively representing CEOs of leading American companies. Through his contributions to both the biopharmaceutical industry and the Chicago community, Richard A. Gonzalez has established himself as a respected leader in the field.

Mr. Gonzalez's association with Abbott Laboratories spans an impressive 30 years, making him a veteran of the company. He served as President and Chief Operating Officer of Abbott before temporarily retiring in 2007. Throughout his tenure at Abbott, he held several senior leadership positions in the medical products businesses, showcasing his versatility and expertise. Notably, he held roles such as President and Chief Operating Officer of the Medical Products Group, Senior Vice President and President of the former Hospital Products Division, Vice President and President of the Health Systems Division, and Divisional Vice President and General Manager for Diagnostics Operations in the United States and Canada.

In addition to his responsibilities at AbbVie, Richard A. Gonzalez is an active member of prestigious organizations such as The Commercial Club of Chicago and The Business Roundtable. These affiliations highlight his commitment to broader industry engagement and leadership.

Throughout his career, Gonzalez has demonstrated a strong track record of success and a deep understanding of the biopharmaceutical industry. His contributions have been pivotal in driving AbbVie's growth and success in delivering innovative healthcare solutions. 

Richard A. Gonzalez holds an undergraduate degree from the University of Houston and a graduate degree from Miami University, further solidifying his foundation of knowledge and expertise.

His vision is centred around improving the lives of patients worldwide by developing and delivering innovative medicines and therapies.

Gonzalez believes in the power of scientific innovation to transform healthcare and make a positive impact on patients' lives. Under his leadership, AbbVie focuses on discovering and developing breakthrough treatments for some of the most challenging and complex diseases. This includes areas such as immunology, oncology, neuroscience, and virology.

Gonzalez's vision extends beyond the development of cutting-edge medicines. He recognizes the importance of patient access to these therapies and is committed to making them available to individuals in need across the globe. This involves collaborating with healthcare systems, payers, and governments to ensure that patients can benefit from AbbVie's advancements and receive the care they require.

In line with his vision, Gonzalez emphasizes the importance of fostering a culture of innovation and collaboration within AbbVie. He encourages a diverse and inclusive workforce that brings together talented individuals from various backgrounds and disciplines to drive forward scientific discovery and breakthroughs.

Furthermore, Gonzalez understands the significance of sustainability and corporate responsibility. He is committed to conducting business in an ethical and responsible manner, focusing on environmental stewardship, social impact, and governance practices. This commitment aligns with his broader vision of creating a sustainable future for healthcare and the well-being of patients.